Contemporary issues in the surgical management of pleural mesothelioma
- PMID: 36630097
- PMCID: PMC9839311
- DOI: 10.1002/jso.27152
Contemporary issues in the surgical management of pleural mesothelioma
Abstract
The surgical management of pleural mesothelioma (PM) can be divided into diagnostic, staging, palliation, and cytoreductive surgery. In the cytoreductive surgical setting, the combination of different treatment modalities has led to better outcomes than surgery alone. The scarcity of high-quality studies has led to heterogeneity in management of PM across the mesothelioma treatment centers. Here, we review the literature regarding the most important open questions and ongoing clinical trials.
Keywords: mesothelioma; multimodality treatment; pleurectomy decortication; surgery.
© 2022 Wiley Periodicals LLC.
Conflict of interest statement
The authors disclose no potential conflicts of interest.
References
-
- Sirri E, Kieschke J, Vohmann C, et al. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population‐based study. Int J Cancer. 2020;147:1548–1558. - PubMed
-
- Paajanen J, Laaksonen S, Ilonen I, et al. Clinical Features in Patients With Malignant Pleural Mesothelioma With 5-Year Survival and Evaluation of Original Diagnoses. Clin Lung Cancer. 2020;21:e633–e639. - PubMed
-
- Paajanen J, Laaksonen S, Kettunen E, et al. Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival. Hum Pathol. 2020;98:110–119. - PubMed
-
- Sauter JL, Dacic S, Galateau-Salle F, et al. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification. J Thorac Oncol. 2022;17:608–622. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
